Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.

Adam Cribbs and Luke Jostins

Associate Professor Adam Cribbs leads a computational biology team with a broad interest in systems biology, immunology and epigenetics. On being named Associate Professor, he said “It’s a great privilege to have been awarded Associate Professor within NDORMS. I owe this recognition because of the hard work and dedication of my DPhil students, postdocs, collaborators and mentors that have allowed my research to flourish.”

Associate Professor Luke Jostins focuses his research on identifying genetic associations with diagnosis or disease prevention in inflammatory bowel disease, and developing statistical techniques to understand the function of genetic risk variants. On being awarded the title Associate Professor, he said “I am delighted and honoured to receive this recognition from the university. I am very grateful to all my group members and collaborators, and particularly to my talented graduate students Benjamin Frot, Alan Yang and Chris Eijsbouts, who worked with me to produce the research that this award recognises.”

Similar stories

Emergency to use the FORCE pathway for wrist fractures in children

New research from the University of Oxford has shown that doctors can simplify treatment for the most common fracture in children, reducing NHS costs.

Kennedy researchers awarded funding to improve the understanding of inflammatory bowel diseases

A new £1.5M grant from the Medical Research Council (MRC) to the Powrie Group at the Kennedy Institute will help define different pathotypes of inflammatory bowel diseases that could lead to better and more focused treatments for patients.

Yoshi Itoh wins the International Dupuytren Award 2022

Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Ten Years of Athena Swan in the Medical Sciences Division

2022 marks ten years since the first Athena Swan Bronze applications from the Medical Sciences Division. Ten years later, and all 16 departments in the Division have achieved a Silver Award. We look at NDORMS’ Athena Swan journey.

Oxford's largest ever study into varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications, establishes for the first time a critical genetic risk score to predict the likelihood of patients suffering with varicose veins to require surgery, as well as pointing the way towards potential new therapies.